Leptin gene therapy and daily protein administration: a comparative study in the ob/ob mouse

Gene Therapy
M A MorsyC T Caskey

Abstract

We have compared the efficacy of daily injection of recombinant leptin protein (rh-leptin) with adenovirus-mediated delivery of the murine or human leptin gene (Ad-leptin) for treatment of obesity in the obese (ob/ob) mouse model. We demonstrate an improved correction profile for obesity and associated surrogate markers using the adenovirus delivery method. Rate of weight loss and percentage satiety were significantly greater in the mice treated with Adleptin. These findings were associated with lower peak serum leptin levels with Ad-leptin (22.9 +/- 2.6 ng/ml for the human gene, and 48.9 +/- 11.5 ng/ml for the murine gene) compared to rh-leptin (385.2 +/- 36.0 ng/ml). (Values are given as mean +/- standard error of the mean.) Importantly rh-leptin and ex vivo-expressed Ad-leptin were equivalently active in a functional cell-based assay. The primary difference in the two therapeutic approaches is the continuous chronic secretion of leptin mediated by gene delivery, versus the intermittent bolus delivery and rapid clearance of the daily injection of rh-leptin protein. Thus, in vivo findings suggest that leptin effects are better achieved at lower steady-state levels, a pharmacological feature attained here by gene therapy. These...Continue Reading

Citations

Mar 1, 2003·Regulatory Peptides·M Friedman-EinatA D Strosberg
Feb 7, 2004·Archives of Gerontology and Geriatrics·D MaugeriP Panebianco
Nov 7, 1998·Molecular and Cellular Endocrinology·C I RosenblumL H Van der Ploeg
Sep 21, 2000·The Proceedings of the Nutrition Society·A MartiJ A Martinez
Apr 17, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sarah N OosmanTimothy J Kieffer
Jul 10, 2002·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Nick Giannoukakis, Paul D Robbins
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·M A MorsyC T Caskey
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·Y T ZhouR H Unger
Jan 6, 2001·AORN Journal·S GoldbergW Homan
Dec 1, 2009·Biochemical and Biophysical Research Communications·Yuan-hui FuTao Hong
Jun 10, 1998·Biochemical and Biophysical Research Communications·A MartiJ A Martinez
Aug 3, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·H DhillonP S Kalra
Aug 8, 2018·Endocrinology·Daniel FergusonCharles A Harris
Jun 28, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·F LarcherJ L Jorcano
Mar 11, 2000·American Journal of Physiology. Endocrinology and Metabolism·R BuettnerR M O'Doherty

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

© 2022 Meta ULC. All rights reserved